Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Pilot Study Using Hydroxytyrosol (HT) as a Dietary Supplement in Patients With Mitochondrial Diseases (MDs)

NCT04543968 is registered in ClinicalTrials.gov with Hong Kong Children's Hospital as lead sponsor.

NCT NCT04543968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04543968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Pilot Study Using Hydroxytyrosol (HT) as a Dietary Supplement in Patients With Mitochondrial Diseases (MDs)
Lead sponsor
Hong Kong Children's Hospital
Phase
Not applicable
Overall status
Completed
Start date
July 5, 2022
Completion date
July 31, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mitochondrial diseases